FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to surface-modified particles, and methods for preparing and using, pharmaceutical suspensions containing said surface-modified particles, and a method for enhancing the active agent internalisation. The surface-modified particles comprise a particle core and a coating coupled with the particle core; the above coating is absorbed on the surface of the particle core wherein the particle core contains a therapeutic agent; the coating contains opsonin, and the surface-modified particle has an average particle size from approximately 1 nm to 2000 nm, and said opsonin is specified in proteins and peptides which bind to the particles or cells so that the phagocytosis ability of the particles or cells increases, wherein pH of the opsonin solution is below an isoelectric point of opsonin.
EFFECT: developing the method for enhancing the active agent internalisation.
35 cl, 11 dwg, 3 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND METHODS FOR THERAPEUTIC MEANS DELIVERY | 2011 |
|
RU2632445C2 |
| METHOD FOR PREPARING SUBMICRON PACLITAXEL PARTICLES | 2004 |
|
RU2402313C2 |
| MAGNETIC NANOPARTICLES FUNCTIONALISED WITH PYROCATECHOL, PRODUCTION AND USE THEREOF | 2015 |
|
RU2687497C2 |
| COMPOSITIONS FOR PROTEIN DELIVERY AND METHODS OF THEIR APPLICATION | 2008 |
|
RU2526904C2 |
| EFFICIENT SYNTHESIS OF ETHYLENEDICYSTEINE-SUGAR CONJUGATES FOR IMAGING AND THERAPY | 2013 |
|
RU2674673C2 |
| PEPTIDE CONJUGATED PARTICLES | 2014 |
|
RU2685186C2 |
| T1 CONTRAST AGENT BASED ON ULTRATHIN IRON OXIDE NANOPARTICLES FOR MAGNETIC RESONANCE IMAGING | 2019 |
|
RU2794613C1 |
| POLYMER SYSTEMS OF DELIVERING ACTIVE SUBSTANCES | 2009 |
|
RU2523714C2 |
| CONSTRUCTED HIGH-AFFINITY HUMAN T-CELL RECEPTORS | 2014 |
|
RU2729383C2 |
| COMPOSITION OF LIPID VESICLES AND METHODS OF APPLICATION | 2011 |
|
RU2595872C2 |
